tiprankstipranks
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX

Lineage Therap (LCTX) Ownership - Who Owns Lineage Therap?

1,794 Followers

Lineage Therap (LCTX) Ownership Overview

75.02%7.00%7.65%10.32%
75.02% Insiders
7.65% Other Institutional Investors
10.32% Public Companies and Individual Investors
The ownership structure of Lineage Therap (LCTX) stock is a mix of institutional, retail and individual investors. Approximately 14.66% of the company’s stock is owned by Institutional Investors, 75.02% is owned by Insiders and 10.32% is owned by Public Companies and Individual Investors.
The ownership structure of Lineage Therap (LCTX) stock is a mix of institutional, retail and individual investors. Approximately 14.66% of the company’s stock is owned by Institutional Investors, 75.02% is owned by Insiders and 10.32% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 08, 2024
Don Bailey
Director
Bought$100001
Feb 08, 2024
Broadwood Partners Lp
Director, >10% Owner
Bought$7000001
Jan 02, 2024Bought$10900

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$10900
Dec 31, 2023Bought$2323466
Dec 31, 2023Sold$5416945

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
83,420,138Insider44.18%90,927,950
34,093,007Insider18.06%37,161,378
7,854,626Institution4.16%8,561,542
7,338,576Institution3.89%7,999,048
6,888,942Insider3.65%7,508,947
4,969,675Institution2.63%5,416,946
4,369,525Institution2.31%4,762,782
2,131,621Institution1.13%2,323,467
1,581,471Institution0.84%1,723,803
1,410,750Institution0.75%1,537,718

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,338,576Institution3.89%7,999,048
1,581,471Institution0.84%1,723,803
1,410,750Institution0.75%1,537,718
767,100Institution0.41%836,139
611,923Institution0.32%666,996
447,020Institution0.24%487,252
363,215Institution0.19%395,904
128,266Institution0.07%139,810
99,941Institution0.05%108,936
67,474Institution0.04%73,547

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,416,552Institution2.34%6,536,497
2,814,846Institution1.49%4,165,972
2,964,515Institution1.57%3,231,321
1,124,024Institution0.60%1,225,186
499,580Institution0.26%739,378
280,986Institution0.15%306,275
115,770Institution0.06%171,340
7,878Institution<0.01%11,659
3,702Institution<0.01%4,331
255Institution<0.01%278

FAQ

Who Owns Lineage Cell Therapeutics, Inc. (LCTX)?
According to the latest TipRanks data, approximately 7.65% of the company's stock is held by institutional investors, 75.02% is held by insiders, and 10.32% is held by retail investors.
    What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 7.65% of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors.
      What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 10.32% of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors.
        Who owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX)?
        Broadwood Partners Lp owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis